10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $87 | -99.9% | 4,700 | -11.0% | 0.01% | +40.0% |
Q3 2022 | $79,000 | +507.7% | 5,280 | +1660.0% | 0.01% | +400.0% |
Q2 2022 | $13,000 | -82.9% | 300 | -95.5% | 0.00% | -75.0% |
Q1 2022 | $76,000 | -46.9% | 6,700 | +69.6% | 0.00% | -33.3% |
Q4 2021 | $143,000 | +32.4% | 3,950 | -42.3% | 0.01% | +20.0% |
Q3 2021 | $108,000 | -24.5% | 6,850 | +661.1% | 0.01% | -16.7% |
Q2 2021 | $143,000 | +297.2% | 900 | +350.0% | 0.01% | +200.0% |
Q1 2021 | $36,000 | -93.7% | 200 | -98.6% | 0.00% | -92.3% |
Q4 2020 | $567,000 | +107.7% | 14,020 | +15.9% | 0.03% | +62.5% |
Q3 2020 | $273,000 | +178.6% | 12,100 | +0.8% | 0.02% | +166.7% |
Q2 2020 | $98,000 | +108.5% | 12,000 | +328.6% | 0.01% | +100.0% |
Q1 2020 | $47,000 | +571.4% | 2,800 | +1300.0% | 0.00% | – |
Q4 2019 | $7,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |